These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 31180552)

  • 61. DNA methylation profiling analysis identifies a DNA methylation signature for predicting prognosis and recurrence of lung adenocarcinoma.
    Wang R; Zhu H; Yang M; Zhu C
    Oncol Lett; 2019 Dec; 18(6):5831-5842. PubMed ID: 31788056
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development and validation of a m
    Zhao X; Cui L
    Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development and validation of a hypoxia-related gene pair signature to predict overall survival in head and neck squamous cell carcinoma.
    Ding Z; Li H; Yu D
    Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):3973-3983. PubMed ID: 33449166
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A novel seven‑miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients.
    Lu L; Wu Y; Feng M; Xue X; Fan Y
    Mol Med Rep; 2019 Nov; 20(5):4340-4348. PubMed ID: 31545440
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Plasma cell-free DNA methylome profiling in pre- and post-surgery oral cavity squamous cell carcinoma.
    Patel KB; Padhya TA; Huang J; Hernandez-Prera JC; Li T; Chung CH; Wang L; Wang X
    Mol Carcinog; 2023 Apr; 62(4):493-502. PubMed ID: 36636912
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Machine learning analysis of DNA methylation in a hypoxia-immune model of oral squamous cell carcinoma.
    Zeng H; Luo M; Chen L; Ma X; Ma X
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107098. PubMed ID: 33091815
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Potential of Oxidative Stress Related Genes as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma.
    Wang X; Zhou G
    Comb Chem High Throughput Screen; 2022; 25(11):1952-1965. PubMed ID: 34875987
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Application of Machine Learning in Developing a Novelty Five-Pseudogene Signature to Predict Prognosis of Head and Neck Squamous Cell Carcinoma: A New Aspect of "Junk Genes" in Biomedical Practice.
    Xing L; Zhang X; Guo M; Zhang X; Liu F
    DNA Cell Biol; 2020 Apr; 39(4):709-723. PubMed ID: 32045271
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of a six-gene prognostic signature for oral squamous cell carcinoma.
    Wang J; Wang Y; Kong F; Han R; Song W; Chen D; Bu L; Wang S; Yue J; Ma L
    J Cell Physiol; 2020 Mar; 235(3):3056-3068. PubMed ID: 31538341
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
    Bhat S; Kabekkodu SP; Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K
    Virchows Arch; 2017 Apr; 470(4):445-454. PubMed ID: 28255813
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
    Misawa Y; Misawa K; Kanazawa T; Uehara T; Endo S; Mochizuki D; Yamatodani T; Carey TE; Mineta H
    Cancer; 2014 Jan; 120(2):205-13. PubMed ID: 24122450
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
    Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Establishment of a Plasticity-Associated Risk Model Based on a SOX2- and SOX9-Related Gene Set in Head and Neck Squamous Cell Carcinoma.
    Khorani K; Schwaerzler J; Burkart S; Kurth I; Holzinger D; Flechtenmacher C; Plinkert PK; Zaoui K; Hess J
    Mol Cancer Res; 2021 Oct; 19(10):1676-1687. PubMed ID: 34285085
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
    Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
    DNA Cell Biol; 2021 Feb; 40(2):247-264. PubMed ID: 33481663
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor.
    De Cecco L; Bossi P; Locati L; Canevari S; Licitra L
    Ann Oncol; 2014 Aug; 25(8):1628-35. PubMed ID: 24827125
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A novel seven-gene panel predicts the sensitivity and prognosis of head and neck squamous cell carcinoma treated with platinum-based radio(chemo)therapy.
    Wang L; Yang Y; Feng L; Tan C; Ma H; He S; Lian M; Wang R; Fang J
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3523-3531. PubMed ID: 33682046
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Weighted gene co-expression network analysis and prognostic analysis identifies hub genes and the molecular mechanism related to head and neck squamous cell carcinoma.
    Li Q; Chen W; Song M; Chen W; Yang Z; Yang A
    Cancer Biol Ther; 2019; 20(6):750-759. PubMed ID: 30900950
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma.
    Burgener JM; Zou J; Zhao Z; Zheng Y; Shen SY; Huang SH; Keshavarzi S; Xu W; Liu FF; Liu G; Waldron JN; Weinreb I; Spreafico A; Siu LL; de Almeida JR; Goldstein DP; Hoffman MM; De Carvalho DD; Bratman SV
    Clin Cancer Res; 2021 Aug; 27(15):4230-4244. PubMed ID: 34158359
    [TBL] [Abstract][Full Text] [Related]  

  • 79. DNA Methylome Distinguishes Head and Neck Cancer from Potentially Malignant Oral Lesions and Healthy Oral Mucosa.
    Milutin Gašperov N; Sabol I; Božinović K; Dediol E; Mravak-Stipetić M; Licastro D; Dal Monego S; Grce M
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961999
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Prognostic and predictive methylation biomarkers in HNSCC : Epigenomic diagnostics for head and neck squamous cell carcinoma (HNSCC)].
    Franzen A; Bootz F; Dietrich D
    HNO; 2020 Dec; 68(12):911-915. PubMed ID: 32613323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.